Dattatray B. Pawar

Mumbai, MH, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

A to Z of Health: An Evidence-Based Narrative Review of Multivitamin-Multimineral and Nutraceutical Supplementation.

A to Z of Health: An Evidence-Based Narrative Review of Multivitamin-Multimineral and Nutraceutical Supplementation.

Journal: Cureus
Published: April 28, 2026

Nimesulide: Critical Appraisal of Safety and Efficacy in Acute Pain.

Nimesulide: Critical Appraisal of Safety and Efficacy in Acute Pain.

Journal: The Journal of the Association of Physicians of India
Published: March 15, 2025

A Prospective, Active-controlled, Randomized, Double-blind, Multicenter, Phase III Study to Compare the Safety and Efficacy of Biosimilar Denosumab vs Reference Denosumab in the Treatment of Postmenopausal Osteoporosis.

A Prospective, Active-controlled, Randomized, Double-blind, Multicenter, Phase III Study to Compare the Safety and Efficacy of Biosimilar Denosumab vs Reference Denosumab in the Treatment of Postmenopausal Osteoporosis.

Journal: The Journal of the Association of Physicians of India
Published: February 02, 2025

A Phase 3 Multicenter, Double-Blind Study Comparing Efficacy, Safety, Immunogenicity, and Pharmacokinetics of Alkem's Biosimilar Teriparatide Versus Reference Teriparatide in Postmenopausal Osteoporosis.

A Phase 3 Multicenter, Double-Blind Study Comparing Efficacy, Safety, Immunogenicity, and Pharmacokinetics of Alkem's Biosimilar Teriparatide Versus Reference Teriparatide in Postmenopausal Osteoporosis.

Journal: Aging medicine (Milton (N.S.W))
Published: September 19, 2024

Cefotaxime Versus Ceftriaxone: A Comprehensive Comparative Review.

Cefotaxime Versus Ceftriaxone: A Comprehensive Comparative Review.

Journal: Cureus
Published: September 10, 2024

Efficacy and Safety of Biosimilar Ranibizumab (OPTIMAB®) versus Innovator Ranibizumab in Patients with Neovascular (Wet) Age-Related Macular Degeneration: A Double-Blind, Randomized, Multicenter, Phase III Study.

Efficacy and Safety of Biosimilar Ranibizumab (OPTIMAB®) versus Innovator Ranibizumab in Patients with Neovascular (Wet) Age-Related Macular Degeneration: A Double-Blind, Randomized, Multicenter, Phase III Study.

Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: September 06, 2024

Exploring the Therapeutic Potential of High Dose Co-amoxiclav (1 gm) in Different Clinical Conditions: A Review.

Exploring the Therapeutic Potential of High Dose Co-amoxiclav (1 gm) in Different Clinical Conditions: A Review.

Journal: Cureus
Published: July 17, 2024

Defeating the Silent Enemy: Antimicrobial Resistance Looming as the Next Global Pandemic.

Defeating the Silent Enemy: Antimicrobial Resistance Looming as the Next Global Pandemic.

Journal: The Journal of the Association of Physicians of India
Published: May 13, 2024

A Comparative Analysis of the Efficacy and Safety of Nimesulide/Paracetamol Fixed-Dose Combination With Other NSAIDs in Acute Pain Management: A Randomized, Prospective, Multicenter, Active-Controlled Study (the SAFE-2 Study).

A Comparative Analysis of the Efficacy and Safety of Nimesulide/Paracetamol Fixed-Dose Combination With Other NSAIDs in Acute Pain Management: A Randomized, Prospective, Multicenter, Active-Controlled Study (the SAFE-2 Study).

Journal: Cureus
Published: April 23, 2024

Long-Term Use of Proton-Pump Inhibitors: Unravelling the Safety Puzzle.

Long-Term Use of Proton-Pump Inhibitors: Unravelling the Safety Puzzle.

Journal: Cureus
Published: January 18, 2024

In Vitro Susceptibility of Clinical Isolates to Ceftriaxone Alone and Ceftriaxone in Combination With Sulbactam or Tazobactam: A Comparative Study of Broad-Spectrum β-Lactam Antibiotics in India.

In Vitro Susceptibility of Clinical Isolates to Ceftriaxone Alone and Ceftriaxone in Combination With Sulbactam or Tazobactam: A Comparative Study of Broad-Spectrum β-Lactam Antibiotics in India.

Journal: Cureus
Published: September 26, 2023

Fixed dose combination of aspirin and pantoprazole: Results of a multicenter, comparative, randomized, double-blind, double dummy, phase III study in Indian patients.

Fixed dose combination of aspirin and pantoprazole: Results of a multicenter, comparative, randomized, double-blind, double dummy, phase III study in Indian patients.

Journal: Indian heart journal
Published: August 03, 2023
Showing 1-12 of 20

Last Updated: 09/26/2026